As alterations in transcript levels may not correspond to protein level changes [41], we next investigated whether the reported downregulation of Willin/FRMD6 transcripts seen in AD patient and mouse model RNA data translated to an Aβ-induced protein level dysregulation. Here, FRMD6 is linked to Alzheimer disease.